D.E. Shaw & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,400
Closed -$4.26M 5172
2025
Q4
$4.26M Sell
9,400
-3,000
-24% -$1.29M ﹤0.01% 2446
2025
Q3
$4.86M Buy
12,400
+7,400
+148% +$3.09M ﹤0.01% 2231
2025
Q2
$2.23M Buy
5,000
+2,800
+127% +$1.29M ﹤0.01% 2665
2025
Q1
$1.07M Buy
+2,200
New +$1.03M ﹤0.01% 3047
2023
Q4
Sell
-1,400
Closed -$487K 4692
2023
Q3
$487K Buy
+1,400
New +$490K ﹤0.01% 3439
2023
Q1
Sell
-8,000
Closed -$2.31M 4964
2022
Q4
$2.31M Hold
8,000
﹤0.01% 2822
2022
Q3
$2.32M Sell
8,000
-10,000
-56% -$2.88M ﹤0.01% 2861
2022
Q2
$5.07M Sell
18,000
-2,400
-12% -$642K 0.01% 2109
2022
Q1
$5.32M Sell
20,400
-30,500
-60% -$7.24M 0.01% 2238
2021
Q4
$11.2M Sell
50,900
-48,300
-49% -$9.39M 0.01% 1566
2021
Q3
$18M Buy
99,200
+40,200
+68% +$7.85M 0.02% 1088
2021
Q2
$11.9M Buy
59,000
+35,000
+146% +$7.32M 0.01% 1355
2021
Q1
$5.16M Buy
+24,000
New +$5.27M 0.01% 1821
2018
Q2
Sell
-25,000
Closed -$4.08M 3939
2018
Q1
$4.08M Buy
25,000
+5,000
+25% +$817K 0.01% 1545
2017
Q4
$3M Hold
20,000
0.01% 1850
2017
Q3
$3.04M Sell
20,000
-20,000
-50% -$3.01M 0.01% 1745
2017
Q2
$5.16M Hold
40,000
0.01% 1310
2017
Q1
$4.37M Hold
40,000
0.01% 1373
2016
Q4
$2.95M Buy
40,000
+27,700
+225% +$2.25M 0.01% 1716
2016
Q3
$1.07M Buy
12,300
+2,300
+23% +$217K ﹤0.01% 2344
2016
Q2
$860K Hold
10,000
﹤0.01% 2505
2016
Q1
$795K Buy
+10,000
New +$905K ﹤0.01% 2513
2015
Q3
Sell
-1,700
Closed -$210K 3932
2015
Q2
$210K Buy
+1,700
New +$214K ﹤0.01% 3565
2014
Q3
Sell
-5,000
Closed -$473K 4479
2014
Q2
$473K Buy
+5,000
New +$351K ﹤0.01% 3574

Other funds holding VRTX